Cargando…
Characterization of CAR T Cells Manufactured Using Genetically Engineered Artificial Antigen Presenting Cells
OBJECTIVE: Chimeric antigen receptor (CAR) T cell therapy has recently emerged as a promising approach for the treatment of different types of cancer. Improving CAR T cell manufacturing in terms of costs and product quality is an important concern for expanding the accessibility of this therapy. One...
Autores principales: | Sayadmanesh, Ali, Azadbakht, Mohammad, Yari, Kheirollah, Abedelahi, Ali, Shafaei, Hajar, Shanehbandi, Dariush, Baradaran, Behzad, Basiri, Mohsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591261/ https://www.ncbi.nlm.nih.gov/pubmed/37865876 http://dx.doi.org/10.22074/CELLJ.2023.2001712.1304 |
Ejemplares similares
-
Generation and Functional Characterization of PLAP CAR-T Cells against Cervical Cancer Cells
por: Yekehfallah, Vahid, et al.
Publicado: (2022) -
Cloning and Expression of CD19, a Human B-Cell Marker in NIH-3T3 Cell Line
por: Abbasi-Kenarsari, Hajar, et al.
Publicado: (2015) -
Downregulation of HMGA2 by Small Interfering RNA Affects the Survival, Migration, and Apoptosis of Prostate Cancer Cell Line
por: Khajouee, Shima, et al.
Publicado: (2022) -
Toll-Like Receptor-Based Strategies for Cancer Immunotherapy
por: Pahlavanneshan, Saghar, et al.
Publicado: (2021) -
IL-4 induces the formation of multinucleated giant cells and
expression of β5 integrin in central giant cell lesion
por: Aghbali, Amirala, et al.
Publicado: (2017)